Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Paul R. Schimmel
Age : 79
Public asset : 3,005,984 USD
Linked companies : aTyr Pharma, Inc.
Summary 
Paul R. Schimmel is an entrepreneur who founded 10 companies, among them: Alnylam Pharmaceuticals, Inc., Repligen Corp. and Cubist Pharmaceuticals LLC.

He is on the board of aTyr Pharma, Inc., Abide Therapeutics, Inc., Kindex Pharmaceuticals, Inc. and Boragen, Inc. and Professor at The Scripps Research Institute, Member of National Academy of Sciences, Member of American Academy of Arts & Sciences, Member of Institute of Medicine, Member of American Philosophical Society, Member of National Academy of Medicine, Member of National Academy of Inventors and Professor at Skaggs Institute For Chemical Biology.

In the past Dr. Schimmel held the position of Co-Chairman at Repligen Corp. (he founded the company in 1981), Member-Scientific Advisory Board at Illumina, Inc., Advisor at CHP Management, Inc., Chairman-Biological Chemistry Division at American Chemical Society, Professor at Massachusetts Institute of Technology, Director at Momenta Pharmaceuticals, Inc., Director at Sirtris Pharmaceuticals, Inc. and Independent Director at Alnylam Pharmaceuticals, Inc.

Dr. Schimmel received an undergraduate degree from Ohio Wesleyan University, a doctorate from Cornell University and a doctorate from Massachusetts Institute of Technology.


Current positions of Paul R. Schimmel 
NameTitle Since
aTyr Pharma, Inc.
(Biotechnology & Medical Research)
Independent Director 2005
Abide Therapeutics, Inc. Director 2012
Kindex Pharmaceuticals, Inc. Director -
The Scripps Research Institute Professor -
Boragen, Inc. Director 2015
National Academy of Sciences Member -
American Academy of Arts & Sciences Member -
Institute of Medicine Member -
American Philosophical Society Member -
National Academy of Medicine Member -
National Academy of Inventors Member -
Skaggs Institute For Chemical Biology Professor -


Holdings of Paul R. Schimmel 
NameEquities%Valuation
aTyr Pharma, Inc. (LIFE)
(Biotechnology & Medical Research)
545,0563.22%3,005,984 USD


Paul R. Schimmel: Personal Network 
Most Read News 
09/04BERNARD ARNAULT : There is no conflict with Arnault
RE
09/07GEORGE SOROS : Soros says BlackRock's China investments likely to lose money - WSJ
RE
09/14BRAD SMITH : Microsoft to buy back up to $60 billion in shares; names Brad Smith vice chair
RE
09/09FRANCESCO GAETANO CALTAGIRONE : Italy's Caltagirone ups Generali stake to just over 6%
RE
09/14CATHIE WOOD : ARK Invest's Wood expects market rotation back to growth stocks
RE
09/09ELON MUSK : Tesla's Musk asks staff to 'go super hardcore' to ensure decent Q3 delivery number
RE
09/13MARTIN SORRELL : Sorrell's S4 Capital raises annual profit outlook for a third time
RE
09/08ELON MUSK : Amazon.com goes for jugular in FCC spat with SpaceX's Musk
RE
09/08BILL GATES : Bill Gates' investment firm to take control of Four Seasons in $2.21 billion deal
RE
09/17STELIOS HAJI-IOANNOU : EasyJet shareholder Stelios Haji-Ioannou shuns rights issue -source
RE
More news


© 2021 People and Ownership :   
Paul R. Schimmel : Connections